1. Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus.
- Author
-
Banas, Bernhard, Krämer, Bernhard K., Krüger, Bernd, Kamar, Nassim, and Undre, Nasrullah
- Subjects
- *
KIDNEY transplantation , *TACROLIMUS - Abstract
Tacrolimus has significantly improved outcomes for kidney transplant patients and remains the cornerstone of immunosuppressive therapy. While improvements in short-term outcomes in transplantation have been achieved in recent years, maintaining long-term graft survival remains a challenge in kidney transplantation. Minimizing risk factors for poor long-term kidney graft function and survival, and modifying tacrolimus regimens in the early and maintenance phases post-transplantation are essential to maintain long-term kidney transplant outcomes. Tacrolimus has a narrow therapeutic window, resulting in a tightly defined range of optimal drug exposure. Underimmunosuppression is associated with long-term risks, such as the development of donor-specific antibodies and antibody-mediated rejection, with a high possibility of a decline in kidney function and progression to graft failure. Conversely, prolonged overimmunosuppression carries a risk of drug-related adverse events. This review provides an overview of the differences in the formulation, delivery, and pharmacokinetic profiles between immediate- and prolonged-release tacrolimus and evaluates the effect of prolonged-release tacrolimus on the risk factors for poor outcomes in kidney transplantation. Recent evidence is used to provide guidance on target tacrolimus trough levels in the early and maintenance phases post-transplantation, with a view to improving long-term kidney graft function. • Tacrolimus is the mainstay of immunosuppression therapy post-kidney transplantation. • Long-term outcomes for kidney transplant recipients remain challenging. • Graft loss risk factors can be managed by immunosuppressive regimen and adherence. • Nonadherence and intrapatient variability in tacrolimus levels predict graft loss. • Prolonged-release tacrolimus could improve long-term kidney transplant outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF